Solar Energy News  
EPIDEMICS
S.African girl, 9, is third child with HIV remission: study
By Mari�tte Le Roux
Paris (AFP) July 24, 2017


A South African girl has become only the third child to beat the AIDS virus into long-term remission -- almost nine years and counting -- after receiving a drug cocktail in infancy, researchers announced Monday.

The child was given a ten-month course of anti-AIDS medicine until she was one year old, then taken off the drugs as part of a medical trial.

Eight years and nine months later, the virus is still dormant and the girl healthy without needing treatment, a research team reported at the International AIDS Society conference on HIV science in Paris.

"This new case strengthens our hope that by treating HIV-infected children for a brief period beginning in infancy, we may be able to spare them the burden of life-long therapy," said AIDS expert Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) which funded the study.

Some scientists refer to sustained, drug-free remission as a "functional cure".

Unlike a traditional cure, where the virus is eradicated, the patient still has HIV in their system but it is so weakened that it cannot replicate or spread to sexual partners.

Researchers hope that by treating people as soon as possible after infection, they can one day induce drug-free remission for sustained periods of time, perhaps for good.

This has become a major focus of research amid fading hopes of finding a permanent cure.

The virus has proven more sneaky than imagined -- it has the ability to hide out in human cells and play dead for years, only to re-emerge and attack as soon as treatment is stopped.

Anti-retroviral (ARV) treatment inhibits the virus, but doesn't kill it, and infected people have to take pills daily for life which are costly and have side-effects.

- Relapse possible -

A rare group of infected people -- fewer than one percent -- are able naturally to stop the virus replicating. They are known as "elite controllers", but the mechanism by which they keep the virus at bay remains a mystery.

The girl does not have "elite controller" DNA, said the study authors.

Among people taking virus-suppressing anti-retroviral drugs, only a few have attained drug-free remission.

They include 14 adults in a French trial who were able to quit their medication after three years and stayed healthy.

A French woman aged 20, treated as a baby, has been healthy for 14 years since stopping her medication -- the longest-known remission.

In the United States, the so-called Mississippi Baby was in remission for 27 months after being given ART for the first 18 months of life, but the virus rebounded in a major let-down for researchers.

Now there is the South African girl -- the first case of remission in a child enrolled in a trial to test the effectiveness of early treatment, for a limited time.

"Relapse is a possibility in any case of remission," underlined study co-leader Avy Violari of the University of the Witwatersrand in Johannesburg.

However, "the fact that remission has been for a long period suggests this is likely to be durable," she told AFP.

Researchers do not understand how the girl achieved remission when 410 other children in the trial did not.

"We can't tell if her immune system would have controlled the virus on its own or if the treatment made a difference," said Sharon Lewin, a professor of medicine at the University of Melbourne.

- 'Impressive' -

The girl was diagnosed HIV-positive on her 32nd day of life. After ten months of treatment, levels of HIV in her blood went from "very high" to undetectible.

Tests conducted when she was nine-and-a-half years old showed the vaguest trace of virus, unable to replicate, said the team. The girl had healthy levels of key immune cells.

Some fear the girl is in a minority of people for whom early treatment is sufficient to induce remission.

"Early treatment is good for lots of reasons. Early treatment stops HIV transmission, early treatment means the immune system stays in better shape and early treatment keeps the (virus) reservoirs small," Lewin told AFP.

"Early treatment may also increase the chance of remission, but more studies are needed to really prove this."

Michael Brady, medical director of the Terrence Higgins Trust, an AIDS charity, said remission was "impressive".

"We just need to understand more about why this is and then find ways to apply it to others," he commented on the study.

The children in the trial were monitored for rebounding virus levels, and the experts stressed it is not a good idea for people to take themselves off ARV treatment.

EPIDEMICS
Women with HIV in Cameroon still stigmatised
Yaounde (AFP) July 24, 2017
Blandine, a 28-year-old mother of a baby girl, sits restlessly on a chair in a women's health centre in Cameroon's capital, not knowing how or what to feel as she waits for an HIV test. Blandine is HIV positive. But the waiting is not for her - it is to find out whether her one-year-old girl also has the human immunodeficiency virus. A few minutes later, she has her answer. "I ... read more

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Algae cultivation technique could advance biofuels

Fungi that evolved to eat wood offer new biomass conversion tool

How enzymes produce hydrogen

New biofuel technology significantly cuts production time

EPIDEMICS
Australia's robo-footballers go for gold at world champs

A robot that grows

Stanford researchers develop a new type of soft, growing robot

Rovers drive through Tenerife darkness

EPIDEMICS
ABB wins $30 million order to support integration of offshore wind energy in the UK

GE's renewables not enough to boost overall revenue

Unbalanced wind farm planning exacerbates fluctuations

Algeria seen as African leader for renewable energy

EPIDEMICS
Cartel probe looms over German car industry

Audi voluntarily recalls up to 850,000 diesel vehicles

World gears up for electric cars despite bumps in road

UK to ban sale of petrol and diesel cars by 2040

EPIDEMICS
New chromium-based superconductor has an unusual electronic state

Molecular microscopy illuminates molecular motor motion

High-temperature superconductivity in B-doped Q-carbon

First direct observation and measurement of ultra-fast moving vortices in superconductors

EPIDEMICS
Underwater robot probes inside Fukushima reactor

Finland's TVO claims partial win in Areva nuclear dispute

Laser-Armed Nuclear Icebreakers: What Russia Has in Store for Arctic

Britain must leave EU nuclear body: Verhofstadt

EPIDEMICS
India must rethink infrastructure needs for 100 new 'smart' cities to be sustainable

Allowable 'carbon budget' most likely overestimated

Sparkling springs aid quest for underground heat energy sources

Google's 'moonshot' factory spins off geothermal unit

EPIDEMICS
Paying farmers not to cut down trees in Uganda helps fight climate change

Eucalyptus gets the chop after deadly Portugal forest fires

Amazon Makes Its Own Rainy Season

EU hauls Poland to top court over ancient forest logging









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.